共 50 条
- [31] Diprovocims: A New and Exceptionally Potent Class of Toll-like Receptor Agonists Boger, Dale L. (dale.boger@outlook.com); Beutler, Bruce (bruce.beutler@utsouthwestern.edu), 1600, American Chemical Society (140):
- [34] Clinical setbacks for toll-like receptor 9 agonists in cancer Nature Biotechnology, 2007, 25 : 825 - 826
- [35] Clinical development of Toll-like receptor-9 agonists ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2007, 57 (01): : 75 - 75